40 results
8-K
EX-99.1
MGTX
MeiraGTx Holdings plc
9 Oct 18
MeiraGTx Announces Acquisition of Vector Neurosciences, Gains Phase 2 Gene Therapy
7:13am
, statements regarding product pipeline, anticipated product benefits, goals and strategic priorities, product candidate development, growth expectations
8-K
EX-99.1
MGTX
MeiraGTx Holdings plc
8 Aug 18
MeiraGTx Reports Second Quarter 2018 Financial Results and Provides Corporate Update
8:17am
product benefits, goals and strategic priorities, product candidate development, growth expectations or targets andpre-clinical and clinical data, as well
8-K
EX-99.1
MGTX
MeiraGTx Holdings plc
8 Nov 18
MeiraGTx Reports Third Quarter 2018 Financial Results and Provides Corporate Update
8:35am
limitation, statements regarding product pipeline, anticipated product benefits, goals and strategic priorities, product candidate development, growth
8-K
EX-99.1
05fnodh 21b
26 Mar 19
MeiraGTx Reports Full Year 2018 Financial Results
4:14pm
S-1
zvf680lp 37ajgod
14 May 18
IPO registration
4:23pm
S-1/A
wrjx3klri
23 May 18
IPO registration (amended)
3:41pm
DRS/A
lexi1fo4
11 May 18
Draft registration statement (amended)
12:00am
424B4
fgfqs6x0195wx9vaw2
8 Jun 18
Prospectus supplement with pricing info
4:56pm